Holdings (Monthly)
Guide ↗
Hartford Healthcare Hls Fund
· Hartford Series Fund Inc| # | Name | Ticker | Since | Shares | Value | % Port | Cat |
|---|---|---|---|---|---|---|---|
| 1 | Eli Lilly & Co | 532457108 | Mar 2026 | 13,727 | $12.6M | 12.09% | EC |
| 2 | Merck & Co Inc | 58933Y105 | Mar 2026 | 58,295 | $7.0M | 6.71% | EC |
| 3 | Johnson & Johnson | 478160104 | Mar 2026 | 25,836 | $6.3M | 6.05% | EC |
| 4 | UnitedHealth Group Inc | 91324P102 | Mar 2026 | 15,880 | $4.3M | 4.11% | EC |
| 5 | Intuitive Surgical Inc | 46120E602 | Mar 2026 | 8,008 | $3.7M | 3.53% | EC |
| 6 | AbbVie Inc | 00287Y109 | Mar 2026 | 15,306 | $3.3M | 3.19% | EC |
| 7 | Abbott Laboratories | 002824100 | Mar 2026 | 29,323 | $3.0M | 2.88% | EC |
| 8 | Danaher Corp | 235851102 | Mar 2026 | 15,625 | $3.0M | 2.84% | EC |
| 9 | Edwards Lifesciences Corp | 28176E108 | Mar 2026 | 35,612 | $2.9M | 2.73% | EC |
| 10 | Vertex Pharmaceuticals Inc | 92532F100 | Mar 2026 | 5,853 | $2.6M | 2.50% | EC |
| 11 | Boston Scientific Corp | 101137107 | Mar 2026 | 36,858 | $2.3M | 2.21% | EC |
| 12 | CVS Health Corp | 126650100 | Mar 2026 | 30,494 | $2.2M | 2.10% | EC |
| 13 | Cencora Inc | 03073E105 | Mar 2026 | 6,558 | $2.1M | 1.97% | EC |
| 14 | Regeneron Pharmaceuticals Inc | 75886F107 | Mar 2026 | 2,529 | $2.0M | 1.87% | EC |
| 15 | HCA Healthcare Inc | 40412C101 | Mar 2026 | 4,101 | $1.9M | 1.86% | EC |
| 16 | Thermo Fisher Scientific Inc | 883556102 | Mar 2026 | 3,624 | $1.8M | 1.71% | EC |
| 17 | Elevance Health Inc | 036752103 | Mar 2026 | 5,698 | $1.7M | 1.60% | EC |
| 18 | Medtronic PLC | 000000000 | Mar 2026 | 17,484 | $1.5M | 1.45% | EC |
| 19 | Cardinal Health Inc | 14149Y108 | Mar 2026 | 6,868 | $1.5M | 1.39% | EC |
| 20 | GSK PLC | 000000000 | Mar 2026 | 51,586 | $1.4M | 1.36% | EC |
| 21 | Agilent Technologies Inc | 00846U101 | Mar 2026 | 11,491 | $1.3M | 1.25% | EC |
| 22 | United Therapeutics Corp | 91307C102 | Mar 2026 | 2,174 | $1.3M | 1.23% | EC |
| 23 | Stryker Corp | 863667101 | Mar 2026 | 3,578 | $1.2M | 1.13% | EC |
| 24 | Argenx SE | 04016X101 | Mar 2026 | 1,529 | $1.1M | 1.07% | EC |
| 25 | UCB SA | 000000000 | Mar 2026 | 3,637 | $1.1M | 1.05% | EC |
| 26 | Dexcom Inc | 252131107 | Mar 2026 | 16,874 | $1.1M | 1.01% | EC |
| 27 | Biogen Inc | 09062X103 | Mar 2026 | 5,481 | $1.0M | 0.96% | EC |
| 28 | Apellis Pharmaceuticals Inc | 03753U106 | Mar 2026 | 23,638 | $951K | 0.91% | EC |
| 29 | STERIS PLC | 000000000 | Mar 2026 | 4,043 | $894K | 0.86% | EC |
| 30 | Ionis Pharmaceuticals Inc | 462222100 | Mar 2026 | 11,237 | $844K | 0.81% | EC |
| 31 | Incyte Corp | 45337C102 | Mar 2026 | 8,743 | $823K | 0.79% | EC |
| 32 | Alnylam Pharmaceuticals Inc | 02043Q107 | Mar 2026 | 2,464 | $815K | 0.78% | EC |
| 33 | Madrigal Pharmaceuticals Inc | 558868105 | Mar 2026 | 1,536 | $804K | 0.77% | EC |
| 34 | Ascendis Pharma A/S | 04351P101 | Mar 2026 | 3,460 | $791K | 0.76% | EC |
| 35 | Bristol-Myers Squibb Co | 110122108 | Mar 2026 | 12,812 | $777K | 0.74% | EC |
| 36 | Elanco Animal Health Inc | 28414H103 | Mar 2026 | 31,004 | $742K | 0.71% | EC |
| 37 | Galderma Group AG | 000000000 | Mar 2026 | 3,695 | $726K | 0.70% | EC |
| 38 | Cytokinetics Inc | 23282W605 | Mar 2026 | 10,815 | $713K | 0.68% | EC |
| 39 | Encompass Health Corp | 29261A100 | Mar 2026 | 6,943 | $672K | 0.64% | EC |
| 40 | Protagonist Therapeutics Inc | 74366E102 | Mar 2026 | 6,317 | $666K | 0.64% | EC |
| 41 | State Street Global Advisors | 857509301 | Mar 2026 | 648,590 | $649K | 0.62% | STIV |
| 42 | Revolution Medicines Inc | 76155X100 | Mar 2026 | 6,612 | $643K | 0.62% | EC |
| 43 | Bio-Techne Corp | 09073M104 | Mar 2026 | 12,008 | $628K | 0.60% | EC |
| 44 | Disc Medicine Inc | 254604101 | Mar 2026 | 9,537 | $610K | 0.58% | EC |
| 45 | Alignment Healthcare Inc | 01625V104 | Mar 2026 | 34,524 | $608K | 0.58% | EC |
| 46 | Pharvaris NV | 000000000 | Mar 2026 | 21,196 | $599K | 0.57% | EC |
| 47 | HeartFlow Inc | 42238D107 | Mar 2026 | 24,312 | $592K | 0.57% | EC |
| 48 | Option Care Health Inc | 68404L201 | Mar 2026 | 20,393 | $549K | 0.53% | EC |
| 49 | Scholar Rock Holding Corp | 80706P103 | Mar 2026 | 10,864 | $534K | 0.51% | EC |
| 50 | ICON PLC | 000000000 | Mar 2026 | 4,813 | $533K | 0.51% | EC |
| 51 | Apogee Therapeutics Inc | 03770N101 | Mar 2026 | 6,243 | $525K | 0.50% | EC |
| 52 | Avantor Inc | 05352A100 | Mar 2026 | 66,012 | $518K | 0.50% | EC |
| 53 | Dianthus Therapeutics Inc | 252828108 | Mar 2026 | 6,126 | $514K | 0.49% | EC |
| 54 | Kymera Therapeutics Inc | 501575104 | Mar 2026 | 6,039 | $503K | 0.48% | EC |
| 55 | PTC Therapeutics Inc | 69366J200 | Mar 2026 | 7,369 | $502K | 0.48% | EC |
| 56 | Mirum Pharmaceuticals Inc | 604749101 | Mar 2026 | 5,399 | $499K | 0.48% | EC |
| 57 | Structure Therapeutics Inc | 86366E106 | Mar 2026 | 10,133 | $488K | 0.47% | EC |
| 58 | Arcus Biosciences Inc | 03969F109 | Mar 2026 | 22,493 | $486K | 0.47% | EC |
| 59 | Natera Inc | 632307104 | Mar 2026 | 2,394 | $479K | 0.46% | EC |
| 60 | Viridian Therapeutics Inc | 92790C104 | Mar 2026 | 24,390 | $477K | 0.46% | EC |
| 61 | QIAGEN NV | 000000000 | Mar 2026 | 11,870 | $475K | 0.46% | EC |
| 62 | Oculis Holding AG | 000000000 | Mar 2026 | 17,442 | $464K | 0.44% | EC |
| 63 | Xenon Pharmaceuticals Inc | 98420N105 | Mar 2026 | 7,624 | $443K | 0.42% | EC |
| 64 | Acadia Healthcare Co Inc | 00404A109 | Mar 2026 | 18,573 | $434K | 0.42% | EC |
| 65 | Adaptive Biotechnologies Corp | 00650F109 | Mar 2026 | 30,861 | $428K | 0.41% | EC |
| 66 | AstraZeneca PLC | 000000000 | Mar 2026 | 2,167 | $427K | 0.41% | EC |
| 67 | Nuvalent Inc | 670703107 | Mar 2026 | 4,103 | $420K | 0.40% | EC |
| 68 | Celldex Therapeutics Inc | 15117B202 | Mar 2026 | 12,569 | $399K | 0.38% | EC |
| 69 | Vaxcyte Inc | 92243G108 | Mar 2026 | 6,840 | $397K | 0.38% | EC |
| 70 | Mineralys Therapeutics Inc | 603170101 | Mar 2026 | 14,421 | $391K | 0.37% | EC |
| 71 | Soleno Therapeutics Inc | 834203309 | Mar 2026 | 11,658 | $390K | 0.37% | EC |
| 72 | GenFleet Therapeutics Shanghai Inc | 000000000 | Mar 2026 | 91,400 | $390K | 0.37% | EC |
| 73 | Inspire Medical Systems Inc | 457730109 | Mar 2026 | 7,432 | $383K | 0.37% | EC |
| 74 | Jiangsu Hengrui Pharmaceuticals Co Ltd | 000000000 | Mar 2026 | 45,725 | $381K | 0.36% | EC |
| 75 | Immunocore Holdings PLC | 45258D105 | Mar 2026 | 12,125 | $366K | 0.35% | EC |
| 76 | Immunome Inc | 45257U108 | Mar 2026 | 16,589 | $363K | 0.35% | EC |
| 77 | Stoke Therapeutics Inc | 86150R107 | Mar 2026 | 10,840 | $353K | 0.34% | EC |
| 78 | Trevi Therapeutics Inc | 89532M101 | Mar 2026 | 28,925 | $345K | 0.33% | EC |
| 79 | Crinetics Pharmaceuticals Inc | 22663K107 | Mar 2026 | 8,142 | $296K | 0.28% | EC |
| 80 | Aktis Oncology Inc | 01021M104 | Mar 2026 | 14,533 | $260K | 0.25% | EC |
| 81 | Newamsterdam Pharma Co NV | 000000000 | Mar 2026 | 7,683 | $246K | 0.24% | EC |
| 82 | CG oncology Inc | 156944100 | Mar 2026 | 1,875 | $127K | 0.12% | EC |
| 83 | Fixed Income Clearing Corp. | 000000000 | Mar 2026 | 112,437 | $112K | 0.11% | RA |
| 84 | Corvus Pharmaceuticals Inc | 221015100 | Mar 2026 | 4,000 | $59K | 0.06% | EC |
| 85 | Eikon Therapeutics Inc | 282564103 | Mar 2026 | 2,100 | $22K | 0.02% | EC |
| 86 | CONTRA ABIOMED INC | 003CVR016 | Mar 2026 | 885 | $903 | 0.00% | DE |